Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Danforth Website

David N. Danforth Jr., M.S., M.D.

Selected Publications

1)  Danforth Jr DN.
Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors.
Breast Cancer Res. 15: 208, 2013.
2)  Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, Lippman ME, Glatstein E, Swain SM, Danforth DN, Camphausen K.
Twenty-five year results of the national cancer institute randomized breast conservation trial.
Breast Cancer Res. Treat. 132: 197-203, 2012.
3)  Danforth DN.
Breast cancer during pregnancy: a comprehensive view.
Cancer J. 16: 68-9, 2010.
4)  Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML, Duelli DM.
Selective release of microRNA species from normal and malignant mammary epithelial cells.
PLoS ONE. 5: e13515, 2010.
5)  Loud JT, Thiébaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH.
Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?.
Cancer Epidemiol. Biomarkers Prev. 18: 1243-51, 2009.
6)  Sportès C, Steinberg SM, Liewehr DJ, Gea-Banacloche J, Danforth DN, Avila DN, Bryant KE, Krumlauf MC, Fowler DH, Pavletic S, Hardy NM, Bishop MR, Gress RE.
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.
Biol. Blood Marrow Transplant. 15: 963-70, 2009.
7)  Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, Plehn J, Doshi A, Thomasson D, McCarthy N, Koeppen H, Sherman M, Zujewski J, Camphausen K, Chen H, Swain SM.
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.
J. Clin. Oncol. 24: 769-77, 2006.
8)  Danforth DN, Abati A, Prindiville SA, Palmieri D, Simon R, Ried T, Steeg PS.
Combined breast ductal lavage and ductal endoscopy for the evaluation of the high risk breast: A feasability study.
J Surg Oncol. 94: 555-564, 2006.
9)  Eng-Wong J, Reynolds JC, Venzon D, Liewehr D, Gantz S, Danforth D, Liu ET, Chow C, Zujewski J.
Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.
J Clin Endocrinol Metab. 91: 3941-3946, 2006.
10)  Abati A, Greene MH, Filie A, Loud J, Prindiville S, Danforth D, Giusti RM.
Quantification of the cellular components of breast duct lavage samples.
Diagn. Cytopathol. 34: 78-81, 2006.
Click Here to View Expanded Bibliography.

This page was last updated on 9/11/2013.